Skip to Main Content

Author Details

Dina Halai
Royal National Orthopaedic Hospital National Health Service Trust
2010
20
18
PMIDPaper TitleJournal TitlePublished Year
34758253100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.N Engl J Med2021
34758253100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report.N Engl J Med2021
29691228The 100â¿¿000 Genomes Project: bringing whole genome sequencing to the NHS.BMJ2018
29691228The 100â¿¿000 Genomes Project: bringing whole genome sequencing to the NHS.BMJ2018
26084801A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.Cancer Discov2015
26084801A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.Cancer Discov2015
26464424Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.J Natl Cancer Inst2015
26464424Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.J Natl Cancer Inst2015
24633157Recurrent PTPRB and PLCG1 mutations in angiosarcoma.Nat Genet2014
24633157Recurrent PTPRB and PLCG1 mutations in angiosarcoma.Nat Genet2014
23175151MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.Br J Cancer2013
23863747Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.Nat Commun2013
23770606Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma.Nat Genet2013
24162739Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.Nat Genet2013
23668430Assessment of MUC4 expression in primary bone tumours.Histopathology2013
23175151MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.Br J Cancer2013
23727862Genome-wide association study identifies two susceptibility loci for osteosarcoma.Nat Genet2013
24162739Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.Nat Genet2013
23863747Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2.Nat Commun2013
23668430Assessment of MUC4 expression in primary bone tumours.Histopathology2013
23770606Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma.Nat Genet2013
23727862Genome-wide association study identifies two susceptibility loci for osteosarcoma.Nat Genet2013
22074548Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes.Histopathology2012
22847733An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.J Pathol2012
22699518Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.Mod Pathol2012
23064415A common single-nucleotide variant in T is strongly associated with chordoma.Nat Genet2012
22074548Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes.Histopathology2012
23064415A common single-nucleotide variant in T is strongly associated with chordoma.Nat Genet2012
22699518Sensitivity of MDM2 amplification and unexpected multiple faint alphoid 12 (alpha 12 satellite sequences) signals in atypical lipomatous tumor.Mod Pathol2012
22847733An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.J Pathol2012
21171078Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.J Pathol2011
21171079The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.J Pathol2011
21171078Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.J Pathol2011
21598255IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.J Pathol2011
22057236Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.Nat Genet2011
22057236Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.Nat Genet2011
21598255IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours.J Pathol2011
21171079The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.J Pathol2011
20407326Primary myxoid liposarcoma of the ovary in an adolescent girl: a case report.Int J Gynecol Pathol2010
20407326Primary myxoid liposarcoma of the ovary in an adolescent girl: a case report.Int J Gynecol Pathol2010
  • 1 - 40 of 40

Recommended Authors

Graduate School of Medicine, Kyoto University
Career Start Year 2012
Number of shared co-authors 1
Institut Curie Hospital
Career Start Year 2010
Number of shared co-authors 2
Guangzhou Kingmed Center for Clinical Laboratory
Career Start Year 2009
Number of shared co-authors 7
University of Basel
Career Start Year 2008
Number of shared co-authors 2
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 0
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 1
Mayo Clinic Foundation
Career Start Year 2007
Number of shared co-authors 0
German Cancer Research Center
Career Start Year 2006
Number of shared co-authors 18
University of California san francisco
Career Start Year 2003
Number of shared co-authors 4
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 15
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 1
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 2000
Number of shared co-authors 6
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 12
From Foundation Medicine
Career Start Year 1999
Number of shared co-authors 10
Washington University School of Medicine and Siteman Cancer Center
Career Start Year 1999
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 3
Memorial Sloan Kettering Cancer Center
Career Start Year 1997
Number of shared co-authors 19
Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto
Career Start Year 1997
Number of shared co-authors 17
Cancer Center of Lyon
Career Start Year 1997
Number of shared co-authors 16
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 17
National Cancer Institute (NCI), National Institutes of Health (NIH)
Career Start Year 1995
Number of shared co-authors 5
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Career Start Year 1994
Number of shared co-authors 18
Brigham and Women's Hospital and Harvard Medical School
Career Start Year 1993
Number of shared co-authors 6
Center for Cancer Research, National Cancer Institute
Career Start Year 1993
Number of shared co-authors 25
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 2
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Career Start Year 1991
Number of shared co-authors 6
University Medical Center Freiburg, University of Freiburg
Career Start Year 1990
Number of shared co-authors 4
PSL Research University, Institut Curie Research Center, INSERM U, Institut Curie
Career Start Year 1987
Number of shared co-authors 28
Memorial Sloan Kettering Cancer Center
Career Start Year 1984
Number of shared co-authors 24
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 58

Collaborators

University College London, UCL Cancer Institute
Co-authored papers 18
University College London, UCL Cancer Institute
Co-authored papers 18
Royal National Orthopaedic Hospital
Co-authored papers 12
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
Wellcome Sanger Institute
Co-authored papers 4
Wellcome Trust Sanger Institute
Co-authored papers 4
Clinica Universidad de Navarra
Co-authored papers 3
University of Navarra, Center for Applied Medical Research
Co-authored papers 3
Wellcome Sanger Institute
Co-authored papers 3
University of Toronto
Co-authored papers 3
University of Toronto
Co-authored papers 3
Garvan Institute of Medical Research
Co-authored papers 3
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 3
Frederick National Laboratory for Cancer Research
Co-authored papers 3
Keck School of Medicine of the University of Southern California
Co-authored papers 3
Wellcome Sanger Institute
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Stanford University School of Medicine
Co-authored papers 3
St Jude Children's Research Hospital
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
Wellcome Sanger Institute
Co-authored papers 3
Institute of Cancer Sciences, University of Glasgow
Co-authored papers 3
Baylor College of Medicine
Co-authored papers 3
The Francis Crick Institute
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
National Cancer Institute
Co-authored papers 3
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 3
IRCCS Istituto Ortopedico Rizzoli
Co-authored papers 3